Abstract
Dyslipidemias are between the most important risk factors of the cardiovascular diseases. Studies with different designs show that the dyslipidemic pattern is clearly heritable and the heritability was estimated to be around 50%. We have analyzed the genetic background of elevated plasma lipids in three studies with different design, all originating from Czech Slavic population. We have examined two small groups of children (N ∼ 90) selected from opposite part of the distribution curve of total cholesterol of 2,000 children; large population of 2,500 individuals selected according the WHO MONICA study criteria and finally 8 years cohort of 250 individuals where substantial decrease of the plasma lipids, as a consequence of the socioeconomic changes, was observed. Alltogether more than 100 variants within different candidate genes were analyzed. Our results showed that especially the variants within the genes for apolipoprotein E, apolipoprotein A5, hepatic lipase and HMGCo-A reductase play a significant role in the determination of the plasma lipid levels. Nutrigenetic analyses suggest an important role of gene environment interactions for variants within apolipoprotein A4, apolipoprotein A5, and cholesterol 7-alpha hydroxylase. However, we were not able to confirm some recent candidates, detected through the genome wide approach. For example the MLXIPL variants exhibit just very marginal effect on plasma triacylglycerols in our Slavic population. Our results point to some generally valid associations between genetic polymorphisms and plasma lipids and underline the importance of the analysis of the gene-gene and gene-environment interactions, as well as the intra-ethnic differences.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Talmud PJ, Humphries SE. Genetic polymorphisms, lipoproteins and coronary artery disease risk. Curr Opin Lipidol. 2001;12:405–9.
Pullinger CR, Kane JP, Malloy MJ. Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders. Expert Rev Cardiovasc Ther. 2003;1:107–19.
Kathiresan S, Willer CJ, Peloso GM, et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet. 2009;41:56–65.
Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE. DNA polymorphism adjacent tohuman apoprotein A-1 gene: relation to hypertriglyceridemia. Lancet. 1983;26:444–6.
Poledne R, Hubáček J, Píša Z, Pistulková H, Valenta Z. Genetic markers in hypercholesterolemic and normocholesterolemic Czech children. Clin Genet. 1994;46:88–91.
Hirschhorn JN. Genetic approaches to studying common diseases and complex traits. Pediatr Res. 2005;57(5 Pt 2):74R–7R.
Bennet AM, Di Angelantonio E, Ye Z, et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA. 2007;298:1300–11.
Hubáček JA, Pistulková H, Valenta Z, Poledne R. Repeat polymorphism in the HMG-CoA reductase gene and hypercholesterolemia. VASA. 1999;28:169–71.
Hubacek JA, Pistulková H, Škodová Z, Berg K, Poledne R. Association between apolipoprotein B promotor haplotypes and cholesterol status. Ann Clin Biochem. 2001;38:399–400.
Hubacek JA, Skodová Z, Lánská V, Adámková V. Apolipoprotein A-V variant (T-1131 > C) affects plasma levels of non-high-density lipoprotein cholesterol in Caucasians. Exp Clin Cardiol. 2008;13:129–32.
Berg K. Level genes and variability genes in the etiology of hyperlipidemia and atherosclerosis. In: Berg K, Retterstól N, Refsum S, editors. From phenotype to genotype in common disorders. Copenhagen: Munksgaard; 1990. p. 77–91.
Phillips CM, Tierney AC, Roche HM. Gene-nutrient interactions in the metabolic syndrome. J Nutrigenet Nutrigenomics. 2008;1:136–51.
Hubáček JA, Pistulková H, Valenta Z, Poledne R. The variability gene effect of apo AII repeat polymorphism in high-cholesterolemic children. Med Sci Mon. 1999;5:605–8.
“MONICA Project”, Manual of operations WHO/MNC 82.2, 1983.
Hubáček JA, Škodová Z, Adámková V, Lánská V, Poledne R. The influence of APOAV polymorphisms (T-1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet. 2004;65:126–30.
Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001;294:169–73.
Hubacek JA, Skodova Z, Adamkova V, Lanska V, Poledne R. Sex-specific effect of APOAV variant (Val153 > Met) on plasma levels of high-density lipoprotein cholesterol. Metabolism. 2005;54:1632–5.
Hubáček JA, Bohuslavová R, Škodová Z, Adámková V. Variants vithin the ghrelin gene – association with HDL-cholesterol, but not with body mass index. Folia Biol (Praha). 2007;53:202–6.
Vrablik M, Ceska R, Adamkova V, et al. MLXIPL variant in individuals with low and high triglyceridemia in white population in Central Europe. Hum Genet. 2008;124:553–5.
Kooner JS, Chambers JC, Aguilar-Salinas CA, et al. Genome wide scan identifies variation in MLXIPL associated with plasma triglycerides. Nat Genet. 2008;40:149–51.
Poledne R, Skodová Z. Changes in nutrition, cholesterol concentration, and cardiovascular disease mortality in the Czech population in the past decade. Nutrition. 2000;16:785–6.
Hubacek JA, Skodova Z, Adamkova V, Lanska V, Pitha J. APOA5 variant Ser19Trp influences a decrease of the total cholesterol in a male 8 year cohort. Clin Biochem. 2006;39:133–6.
Hubacek JA, Bohuslavova R, Skodova Z, Pitha J, Bobkova D, Poledne R. Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change. Clin Chem Lab Med. 2007;45:316–20.
Hubacek JA, Berge KE, Štefková J, et al. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels. Physiol Res. 2004;53:395–401.
Hubacek JA, Pitha J, Skodova Z, et al. Polymorphisms in CYP-7A1, not APOE, influence the change in plasma lipids in response to population dietary change in an 8 year follow-up; results from the Czech MONICA study. Clin Biochem. 2003;36:263–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hubacek, J.A., Poledne, R. (2011). Genes and Plasma Lipids in Czech Slavic Population. In: Ostadal, B., Nagano, M., Dhalla, N. (eds) Genes and Cardiovascular Function. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7207-1_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7207-1_15
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7206-4
Online ISBN: 978-1-4419-7207-1
eBook Packages: MedicineMedicine (R0)